Table 1.
Baseline of clinical and laboratory characteristics of women with tubal etiology infertility with and without antiphospholipid antibodies (aPL, aCL and/or aB2GPi antibodies).
| Characteristics | aPL positive (n=44) | aPL negative (n=88) | p-value |
|---|---|---|---|
| Age (years) | 30.9 ± 2.7 | 30.4 ± 3.5 | 0.466 |
| Duration of infertility (years) | 3.3 ± 2.2 | 2.9 ± 2.0 | 0.324 |
| BMI (kg/m2) | 23.0 ± 2.9 | 22.5 ± 2.8 | 0.314 |
| AMH (ng/ml) | 3.9 ± 3.1 | 4.3 ± 2.7 | 0.644 |
| Basal FSH (IU/L) | 6.2 ± 1.7 | 6.6 ± 1.4 | 0.279 |
| Basal LH (IU/L) | 4.3 ± 1.8 | 4.0 ± 1.6 | 0.408 |
| Basal E2 (pg/ml) | 46.6 ± 17.3 | 43.2 ± 17.6 | 0.395 |
| PRL (ng/ml) | 13.9 ± 6.0 | 12.6 ± 4.8 | 0.262 |
| LH level on hCG day (IU/L) | 1.4 ± 0.9 | 1.6 ± 0.7 | 0.228 |
| E2 level on hCG day (pg/ml) | 2901.0 ± 1472.3 | 3189.3 ± 1335.8 | 0.259 |
| P level on hCG day (ng/ml) | 0.9 ± 0.6 | 0.9 ± 0.4 | 0.753 |
| TSH (mIU/L) | 2.1 ± 0.8 | 2.2 ± 0.8 | 0.734 |
| FT4 (pmol/L) | 17.1 ± 2.8 | 17.2 ± 2.7 | 0.810 |
| FT3 (pmol/L) | 4.9 ± 0.7 | 5.0 ± 0.6 | 0.578 |
| FBG (mmol/L) | 5.1 ± 0.7 | 5.0 ± 0.3 | 0.336 |
| INS (pmol/L) | 71.1 ± 31.9 | 67.1 ± 28.8 | 0.350 |
| CA125 (U/ml) | 15.5 ± 5.3 | 15.3 ± 5.5 | 0.856 |
| D-D(ug/ml) | 0.4 ± 0.2 | 0.4 ± 0.2 | 0.372 |
| HCY (umol/L) | 6.9 ± 1.5 | 6.5 ± 1.8 | 0.276 |
| Vitamin D level (ng/ml) | 15.7 ± 4.6 | 17.1 ± 5.5 | 0.165 |
The data were represented by mean ± SD unless otherwise stated. P-value <0.05 was considered to be statistically significant.
BMI, body mass index; AMH, anti-Müllerian hormone; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; PRL, prolactin; TSH, thyroid stimulating hormone; FT4, free tetraiodothyronine; FT3, free triiodothyronine; FBG, fasting blood glucose; INS, fasting insulin; CA125, cancer antigen 125; D-D, D-Dimer; HCY, homocysteine.